NPSP: Summary for NPS Pharmaceuticals, Inc. - Yahoo! Canada Finance

MORE ON NPSP

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

NPS Pharmaceuticals, Inc. (NGM:NPSP) Delayed quote data

Last Trade:	3.21 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	3.21
Open:	N/A
Bid:	3.05 x 200
Ask:	3.49 x 200
1y Target Est:	7.33

Day's Range:	N/A - N/A
52wk Range:	2.74 - 6.79
Volume:	0
Avg Vol (3m):	172,816
Market Cap:	155.45M
P/E (ttm):	N/A
EPS (ttm):	-0.51
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add NPSP to Portfolio

Download Data

HEADLINES

•	NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
	Business Wire (Tue, Feb 2)

•	NPS PHARMACEUTICALS INC Files SEC form 8-K, Other Events
	EDGAR Online (Fri, Jan 22)

•	5-Star Stocks on the Upswing
	at Motley Fool (Wed, Jan 13)

•	5 Top Stocks at Half Price
	at Motley Fool (Tue, Dec 22)

•	NPS PHARMACEUTICALS INC Files SEC form 8-K, Other Events
	EDGAR Online (Wed, Dec 9)

•	NPS PHARMACEUTICALS INC Financials
	EDGAR Online Financials (Tue, Nov 10)

•	NPS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Thu, Nov 5)

•	NPS Pharmaceuticals Earnings Call scheduled for 5:00 pm ET today
	CCBN (Wed, Nov 4)

•	NPS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
	EDGAR Online (Wed, Nov 4)

•	Onyx To Buy Drugmaker For $276 Million
	at Forbes.com (Mon, Oct 12)

More Headlines for NPSP...

ANALYST

EPS Est (next year) (Dec-09) :	-0.47
EPS Est (in 2 years) (Dec-10) :	-0.43
Avg Rec (current)*:	1.7
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of specialty therapeutics for gastrointestinal and endocrine disorders.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

NPS Pharmaceuticals, Inc. (NPSP)